Ancient Viruses Offer Future Promises

Imbedded in the genomes of creatures as varied as mouse and man are retroviral remnants. These artifacts of ancient infections result from RNA viruses inserting DNA copies of themselves into their hosts' genomes. Sometimes they hit the jackpot and make their way into the germ line. Sorted and shuffled over the eons, some of these ancient endogenous viruses have serendipitously developed the ability to shield cells against new viruses. Research on retroviruses and resistance to them in mice and o

Written byBrendan Maher
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Research on retroviruses and resistance to them in mice and other organisms surged when the war on cancer was declared in 1971. As scientists began to realize, however, that retroviruses played less of a role in cancer than previously thought, research diminished—only to be rekindled by the AIDS blight in the 1980s. "We'd be nowhere on HIV if there hadn't been years studying these weird mouse viruses," says David Sanders, associate professor, Markey Center for Structural Biology, Purdue University department of biosciences, who works with the Fv-4 resistance gene. Though questions remain—especially about the immune system's role in resistance—Sanders and other researchers hope that the information they uncover could lead to gene therapies that can fight the spread of HIV.

Sanders and his team believe they have pinpointed the amino acid sequence that causes this interference.1 In addition, according to Sander's paper, if per chance a cell is infected, Fv-4 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies